Polyphenols and pectin enriched golden kiwifruit (Actinidia chinensis) alleviates high fructose-induced glucolipid disorders and hepatic oxidative damage in rats:in association with improvement of fatty acids metabolism

This study aimed to investigate the protective effects of fleshes from two Actinidia chinensis(ACF), pericarps from two A. chinensis(ACP), and fleshes with pericarps from two A. chinensis(ACFP)on high fructose(HF)-instigated dyslipidemia, hepatic steatosis, oxidative stress, insulin resistance, and fatty acid metabolism disorders in rats. In general, the above abnormalities were improved after 10 weeks intervention of ACF, ACP, and ACFP. Especially, ACFP considerably ameliorated HF-induced abnormal changes in body weight gain, serum TC, TG, LDL-C and HDL-C levels, as well as serum and hepatic SFAs, MUFAs and PUFAs contents. ACFP also alleviated HF-induced hyperglycemia and hyperinsulinemia, stabilized HF-caused increase in hepatic MDA and serum ALT, AST levels, and restored HF-declined hepatic T-SOD and GSH-Px activities. Besides, histopathology of the liver further endorsed the protective effects of ACFP on hepatocellular injury. Moreover, ACFP increased HF-dropped acetic, propionic and butyric acid levels. Overall, ACFP employs more efficacious protective effects against HF-induced metabolic disorders and liver damage than ACF and ACP. This study delivers a scientific foundation for developing kiwifruit(counting peel)-based dietary supplements for those with glucolipid-metabolic disorders and liver damage.

Degradation of tiamulin by a packed bed dielectric barrier plasma combined with TiO_(2)catalyst

Recently,a plasma catalyst was employed to efflciently degrade antibiotic residues in the environment.In this study,the plasma generated in a packed bed dielectric barrier reactor combined with TiO_(2)catalyst is used to degrade the antibiotic tiamulin(TIA)loaded on the surface of simulated soil particles.The effects of applied voltage,composition of the working gas,gas flow rate and presence or absence of catalyst on the degradation effect were studied.It was found that plasma and catalyst can produce a synergistic effect under optimal conditions(applied voltage 25 k V,oxygen ratio 1%,gas flow rate 0.6 l min^(-1),treatment time 5 min).The degradation efflciency of the plasma combined with catalyst can reach 78.6%,which is 18.4%higher than that of plasma without catalyst.When the applied voltage is 30 k V,the gas flow rate is 1 l min^(-1),the oxygen ratio is 1%and the plasma combined with TiO_(2)catalyst treats the sample for 5 min the degradation efflciency of TIA reached 97%.It can be concluded that a higher applied voltage and longer processing times not only lead to more degradation but also result in a lower energy efflciency.Decreasing the oxygen ratio and gas flow rate could improve the degradation efflciency.The relative distribution and identity of the major TIA degradation product generated was determined by high-performance liquid chromatography–mass spectrometry analysis.The mechanism of TIA removal by plasma and TiO_(2)catalyst was analyzed,and the possible degradation path is discussed.

Efficacy,safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants

A randomized,double-blind,placebo-controlled multicenter trial was conducted in healthy Chinese infants to assess the efficacy and safety of a hexavalent live human-bovine reassortant rotavirus vaccine(HRV)against rotavirus gastroenteritis(RVGE).A total of 6400 participants aged 6-12 weeks were enrolled and randomly assigned to either HRV(n?3200)or placebo(n?3200)group.All the subjects received three oral doses of vaccine four weeks apart.The vaccine efficacy(VE)against RVGE caused by rotavirus serotypes contained in HRV was evaluated from 14 days after three doses of administration up until the end of the second rotavirus season.VE against severe RVGE,VE against RVGE hospitalization caused by serotypes contained in HRV,and VE against RVGE,severe RVGE,and RVGE hospitalization caused by natural infection of any serotype of rotavirus were also investigated.All adverse events(AEs)were collected for 30 days after each dose.Serious AEs(SAEs)and intussusception cases were collected during the entire study.Our data showed that VE against RVGE caused by serotypes contained in HRV was 69.21%(95%CI:53.31-79.69).VE against severe RVGE and RVGE hospitalization caused by serotypes contained in HRV were 91.36%(95%CI:78.45-96.53)and 89.21%(95%CI:64.51-96.72)respectively.VE against RVGE,severe RVGE,and RVGE hospitalization caused by natural infection of any serotype of rotavirus were 62.88%(95%CI:49.11-72.92),85.51%(95%CI:72.74-92.30)and 83.68%(95%CI:61.34-93.11).Incidences of AEs from the first dose to one month post the third dose in HRV and placebo groups were comparable.There was no significant difference in incidences of SAEs in HRV and placebo groups.This study shows that this hexavalent reassortant rotavirus vaccine is an effective,well-tolerated,and safe vaccine for Chinese infants.

Alternative splicing of inner-ear-expressed genes

Alternative splicing plays a fundamental role in the development and physiological function of the inner ear. Inner-ear-specific gene splicing is necessary to establish the identity and maintain the function of the inner ear. For example, exon 68 of Cadherin 23 （Cdh23） gene is subject to inner-ear-specific alternative splicing, and as a result, Cdh23（＋ 68） is only expressed in inner ear hair cells. Alternative splicing along the tonotopic axis of the cochlea contributes to frequency tuning, particularly in lower vertebrates, such as chickens and turtles. Differential splicing of Kcnmal, which encodes for the a subunit of the Ca2＋-activated K~ channel （BK channel）, has been suggested to affect the channel gating properties and is important for frequency tuning. Consequently, deficits in alternative splicing have been shown to cause hearing loss, as we can observe in Bronx Waltzer Cov） mice and Sfswap mutant mice. Despite the advances in this field, the regulation of alternative splicing in the inner ear remains elusive. Further investigation is also needed to clarify the mechanism of hearing loss caused by alternative splicing deficits.

Robust Control Strategy of Gradient Magnetic Drive for Microrobots Based on Extended State Observer

Microrobots have great application pot ential in the biomedical field,to realize the precision and eficiency of microrobots in vivo is research focus in this field.Microrobots are accompanied by various disturbances in complex environment.These disturbances will affect the motion control of microrobots,resulting in the inability of the micromanipulation tasks to be completed effectively.To this end,a robust motion control method is proposed for precise path tracking of microrobots in this paper.The extended state observer(ESO)is used to estimate the total disturbances and uncertainties of the system.A path tracking controller is designed by combining sliding mode control(SMC)and disturbances compensation,which is used to eliminate the total disturbances of the system and realize the fast and accurate path tracking of microrobots.Finally,the path tracking experiments are implemented in the gradient magnetic field drive system.The experimental results show that the mean absolute error of the path tracking for microrobots in a simulated vascular structure is less than 14μm,and the root mean square error is less than 17 um by using the robust control method proposed in this paper.Compared with the traditional PID control method,it can better suppress external disturbances and uncertainties of the system and improve the path tracking accuracy of microrobots efectively.It shows stronger anti interference ability and robustness.